Big Move For Cyclo Therapeutics Inc.

Fri, Jan 12, 2024 at 07:38 PM

Cyclo Therapeutics Inc. (CYTH:NASDAQ) shot up at $1.86, representing a gain of 31%. On Fri, Jan 12, 2024, CYTH:NASDAQ touched a New 2-Week High of $1.86. The stock got featured on our News Catalysts scanner on Wed, Dec 27, 2023 at 07:10 PM in the 'MERGER' category. From Fri, Dec 29, 2023, the stock recorded 33.33% Up Days and 60.00% Green Days

About Cyclo Therapeutics Inc. (CYTH:NASDAQ)

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease.

Top 10 Gainers:

Applied UV Inc. (AUVI:NASDAQ), 67.11%
Atreca, Inc. (BCEL:NASDAQ), 52.63%
SRIVARU Holding Limited (SVMH:NASDAQ), 46.21%
Vinco Ventures Inc. (BBIG:NASDAQ), 42.86%
SYLA Technologies Co. Ltd. (SYT:NASDAQ), 36.1%
Entera Bio Ltd. (ENTX:NASDAQ), 35.17%
Nubia Brand International Corp. (NUBI:NASDAQ), 33.4%
Cyclo Therapeutics Inc. (CYTH:NASDAQ), 30.99%
Nuburu Inc. (BURU:NYSEMKT), 29.25%
Elevation Oncology Inc. (ELEV:NASDAQ), 29.25%